AstraZeneca says 'no final diagnosis' in Oxford University COVID-19 vaccine trial participant

Author : News Master Published: September 09, 2020

Share on Facebook Share on Google+

The company behind the stage 3 clinical trials of the Oxford University COVID-19 vaccine candidate says reports that a participant has a confirmed case of transverse myelitis are "incorrect".

from ABC News https://ift.tt/35lFzqB
via